We are delighted to announce that Odelle Technology are now members of EIT Health Ireland-UK as a network partner, providing us with a wonderful opportunity to expand our business network…
News
-
-
Germany’s healthcare system has established a robust framework for integrating and reimbursing artificial intelligence (AI) technologies, particularly through the Digital Healthcare Act (DVG). This system ensures AI tools can be…
-
News
Dutch Healthcare Authority Updates Policy Framework for Small-Scale Experiments: A Detailed Analysis
On 25 November 2024, the Dutch Healthcare Authority (NZa) announced significant updates to the policy framework for small-scale experiments aimed at fostering healthcare innovation. These updates refine the process by which healthcare…
-
News
Assessing and Measuring Positive Healthcare Effects in Germany’s Digital Health Applications (DiGA)
The Digital Health Applications (DiGA) framework, established under the Digital Healthcare Act (DVG) in 2019, allows certain digital health apps to be prescribed by physicians and reimbursed by statutory health…
-
In the dynamic realm of healthcare, digital health solutions are rapidly emerging as pivotal tools, particularly for managing chronic conditions. Unlike traditional pharmaceutical therapies, digital health applications (apps) offer scalable,…
-
News
Revolutionising Sepsis Diagnosis: The Science and Clinical Impact of Cytovale’s IntelliSep Test
Sepsis remains one of the most critical challenges in emergency medicine, often leading to high mortality rates due to its rapid progression and the necessity for swift intervention. Traditional diagnostic…
-
News
Navigating the Complex Landscape of Digital Health Assessments: A Deep Dive into Finland’s Digi-HTA and France’s PECAN Frameworks
In the rapidly evolving realm of digital health, ensuring that innovative technologies are both safe and effective is paramount. For digital health manufacturers, understanding and navigating the assessment frameworks that…
-
As we mark Breast Cancer Awareness Month, it’s vital to highlight the progress being made in the tools we use to diagnose and treat this complex disease. Among the latest innovations…
-
In Spain, getting in vitro diagnostics (IVDs) reimbursed involves navigating distinct pathways, each with its focus and requirements. The three primary systems are theSpanish Catalogue of Health Products, the Common…
-
News
GSK Invests £50 Million into a Groundbreaking Partnership with Cambridge: Tackling Immune-Related Diseases
GSK is taking a bold step forward in the fight against immune-related diseases by investing £50 million into a new five-year collaboration with the University of Cambridge and Cambridge University Hospitals. Dubbed the Cambridge-GSK Translational…